Informazioni generali
  • Categoria della malattia Malattie cerebrali (non cancro) , Malattie del sistema nervoso (BASEC)
  • Fase dello studio N/A (ICTRP)
  • Stato di reclutamento reclutamento in corso (BASEC/ICTRP)
  • Luogo dello studio
    Luzern, Zurigo
    (BASEC)
  • Responsabile dello studio Nora-Hjördis Moser stimuloop@usz.ch (BASEC)
  • Fonte dati BASEC: Importato da 27.03.2025 ICTRP: Importato da 09.10.2024
  • Ultimo aggiornamento 27.03.2025 07:46
HumRes63734 | SNCTP000005799 | BASEC2023-01400 | NCT06608875

StimuLOOP.PD – Sensory-Motor Precision Neuro-Rehabilitation through Personalized Stimulation Loops for Patients with Parkinson's

  • Categoria della malattia Malattie cerebrali (non cancro) , Malattie del sistema nervoso (BASEC)
  • Fase dello studio N/A (ICTRP)
  • Stato di reclutamento reclutamento in corso (BASEC/ICTRP)
  • Luogo dello studio
    Luzern, Zurigo
    (BASEC)
  • Responsabile dello studio Nora-Hjördis Moser stimuloop@usz.ch (BASEC)
  • Fonte dati BASEC: Importato da 27.03.2025 ICTRP: Importato da 09.10.2024
  • Ultimo aggiornamento 27.03.2025 07:46

Descrizione riassuntiva dello studio

The aim of the study is to improve walking function in patients with Parkinson's. Specifically, we want to find out whether personalized rehabilitation training tailored to their individual needs and the reinforcement of learned skills during sleep can improve gait quality and mobility more quickly and sustainably. We hope to use this information to enable more effective rehabilitation for Parkinson's patients in the future.

(BASEC)

Intervento studiato

In our study, there are two groups:

• Group 1 (control group) receives the intervention method of personalized rehabilitation without additional reinforcement of learned skills during sleep.

• Group 2 (experimental group) receives the intervention method of personalized rehabilitation with additional reinforcement of learned skills during sleep.

(BASEC)

Malattie studiate

Parkinson's with gait disturbance

(BASEC)

Criteri di partecipazione
- Diagnosis of idiopathic Parkinson's syndrome - UPDRS III: postural instability score 1-3 - UPDRS III: gait score 1-3 (BASEC)

Criteri di esclusione
- Cognitive impairment, Montreal Cognitive Assessment (MoCa) < 20 - Global aphasia that makes understanding study-related information impossible - Other neurological or other conditions causing persistent clinically significant gait or balance disturbances (BASEC)

Luogo dello studio

Luzern, Zurigo

(BASEC)

Switzerland (ICTRP)

Sponsor

Prof. Dr. med. Christian Baumann Universitätsspital Zürich

(BASEC)

Contatto per ulteriori informazioni sullo studio

Persona di contatto in Svizzera

Nora-Hjördis Moser

043 253 95 67

stimuloop@usz.ch

Universitätsspital Zürich

(BASEC)

Informazioni generali

+41 44 255 86 15

Angelina.Maric@usz.ch

(ICTRP)

Informazioni scientifiche

+41 44 255 86 15

Angelina.Maric@usz.ch

(ICTRP)

Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)

Commissione d'etica svizzera nord-ovest/centrale EKNZ

(BASEC)

Data di approvazione del comitato etico

09.02.2024

(BASEC)


ID di studio ICTRP
NCT06608875 (ICTRP)

Titolo ufficiale (approvato dal comitato etico)
Precision sensorimotor neurorehabilitation through personalized stimulation loops in a proof-of-principle study (BASEC)

Titolo accademico
Precision Sensorimotor Neurorehabilitation Through Personalized Stimulation Loops in a Proof-of-principle Study (ICTRP)

Titolo pubblico
Precision Sensorimotor Neurorehabilitation Through Personalized Stimulation Loops (ICTRP)

Malattie studiate
Parkinson Disease (ICTRP)

Intervento studiato
Behavioral: Hyper-personalized feedback (HPF intervention);Behavioral: Targeted auditory stimulation during sleep (TASS verum intervention);Behavioral: Control targeted auditory stimulation during sleep (TASS sham intervention) (ICTRP)

Tipo di studio
Interventional (ICTRP)

Disegno dello studio
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor). (ICTRP)

Criteri di inclusione/esclusione
Gender: All
Maximum age: N/A
Minimum age: 18 Years
Inclusion Criteria:

- Idiopathic Parkinson's disease with gait and postural stability deficits

- =18 years of age

- United Parkinson Disease Rating Scale (UPDRS) III gait scores 1-3

- UPDRS III postural instability scores 1-3

- Prescribed rehabilitation therapy at cereneo

- Informed consent as documented by signature

- Adjustments in dopaminergic medication and deep brain stimulation (DBS) to improve
motor symptoms implemented to the current best possible extent

Exclusion Criteria:

- Cognitive impairment, Montreal Cognitive Assessment (MoCa) < 20

- Comprehensive aphasia precluding the understanding of study-related information

- Other neurological or medical condition that caused sustained clinically relevant
gait and/or postural stability deficits

- Expected acute hospitalization during the training period

- History of a physical or neurological condition that interferes with study
procedures

- Social and/or personal circumstances that interfere with the ability to return for
therapy sessions and follow-up assessments

- Not capable of voluntary gait adaptation

- Patients taking benzodiazepines or Z-drugs that have a significant effect on sleep
EEG

- Recent DBS implant (= 6 months)

- Inability to perform outcome assessments without walking aid

- Skin disorders/problems/allergies in face/ear area that could worsen with electrode
application (e.g. nickel allergy) (ICTRP)

non disponibile

Endpoint primari e secondari
6 min walking test;MiniBEST test (ICTRP)

Phase Coordination Index;Continuous Relative Phase;Variability;Symmetry;Margin of Stability;Resilience (ICTRP)

Data di registrazione
non disponibile

Inclusione del primo partecipante
non disponibile

Sponsor secondari
ETH Zurich (Switzerland);Cereneo AG;University Children's Hospital, Zurich;Lake Lucerne Institute AG (ICTRP)

Contatti aggiuntivi
Angelina Maric, Angelina.Maric@usz.ch, +41 44 255 86 15 (ICTRP)

ID secondari
2023-01400 (ICTRP)

Risultati-Dati individuali dei partecipanti
non disponibile

Ulteriori informazioni sullo studio
https://clinicaltrials.gov/ct2/show/NCT06608875 (ICTRP)

Risultati dello studio

Riepilogo dei risultati

non disponibile

Link ai risultati nel registro primario

non disponibile